Depression, anxiety, and apathy in Parkinson's disease: Insights from neuroimaging studies

European Journal of Neurology

Volumn 23, Issue 6, 2016, Pages 1001-1019

  Wen, M C ^a   Chan, L L ^b   Tan, L C S ^a,c   Tan, E K ^a,c  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Anxiety; Apathy; Depression; Frontostriatal pathway; Neuroimaging; Parkinson's disease

Indexed keywords

AMYGDALA; ANXIETY; APATHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORPUS STRIATUM; DEPRESSION; HUMAN; NEUROIMAGING; NIGRONEOSTRIATAL SYSTEM; PARIETAL CORTEX; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; TEMPORAL CORTEX; THALAMUS; BRAIN; COMPLICATION; DIAGNOSTIC IMAGING; IMAGE PROCESSING; PHYSIOLOGY; PSYCHOLOGY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ANXIETY; APATHY; BRAIN; DEPRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEUROIMAGING; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84964906232     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.13002     Document Type: Review

References (72)

1. Gallagher D, Schrag A. Psychosis, apathy, depression and anxiety in Parkinson's disease. Neurobiol Dis 2012; 46: 581-589.
2. Reijnders J, Ehrt U, Weber W, Aarsland D, Leentjens A. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008; 23: 183-189.
3. Karlsen K, Tandberg E, Arsland D, Larsen J. Health related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry 2000; 69: 584-589.
4. Pontone G, Williams J, Anderson K, et al. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord 2009; 24: 1333-1338.
5. Pont-Sunyer C, Hotter A, Gaig C, et al. The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study). Mov Disord 2015; 30: 229-237.
6. Richard I. Anxiety disorders in Parkinson's disease. Adv Neurol 2005; 96: 42-55.
7. den Brok M, van Dalen J, van Gool W, Moll van Charante E, de Bie R, Richard E. Apathy in Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2015; 30: 79-769.
8. Leentjens A. Depression in Parkinson's disease: conceptual issues and clinical challenges. J Geriatr Psychiatry Neurol 2004; 17: 120-126.
9. Marinus J, Leentjens A, Visser M, Stiggelbout A, van Hilten J. Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol 2002; 25: 318-324.
10. Kano O, Ikeda K, Cridebring D, Takazawa T, Yoshii Y, Iwasaki Y. Neurobiology of depression and anxiety in Parkinson's disease. Parkinsons Dis 2011; 2011: 143547.
11. Ballanger B, Klinger H, Eche J, et al. Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease. Mov Disord 2012; 27: 84-89.
12. Bohnen N, Kaufer D, Hendrickson R, Constantine G, Mathis C, Moore R. Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia. J Neurol Neurosurg Psychiatry 2007; 78: 641-643.
13. 11C]DASB. Mov Disord 2008; 23: 1776-1780.
14. 18F fluorodeoxyglucose positron emission computed tomography study. Dement Geriatr Cogn Disord 2013; 35: 183-196.
15. Mayberg H, Starkstein S, Sadzot B, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990; 28: 57-64.
16. Mentis MJ, McIntosh AR, Perrine K, et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 2002; 159: 746-754.
17. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005; 128: 1314-1322.
18. Politis M, Wu K, Loane C, et al. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 2010; 75: 1920-1927.
19. Guttman M, Boileau I, Warsh J, et al. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. Eur J Neurol 2007; 14: 523-528.
20. Ceravolo R, Frosini D, Poletti M, et al. Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction. Eur J Neurol 2013; 20: 480-485.
21. Felicio A, Moriyama T, Godeiro-Junior C, et al. Higher dopamine transporter density in Parkinson's disease patients with depression. Psychopharmacology 2010; 211: 27-31.
22. Hesse S, Meyer PM, Strecker K, et al. Monoamine transporter availability in Parkinson's disease patients with or without depression. Eur J Nucl Med Mol Imaging 2009; 36: 428-435.
23. Imamura K, Okayasu N, Nagatsu T. The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment. Acta Neurol Scand 2011; 124: 28-39.
24. Matsui H, Nishinaka K, Oda M, Komatsu K, Kubori T, Udaka F. Minor depression and brain perfusion images in Parkinson's disease. Mov Disord 2006; 21: 1169-1174.
25. Pålhagen S, Ekberg S, Wålinder J, Granérus A, Granerus G. HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment. J Neurol 2009; 256: 1510-1518.
26. Rektorova I, Srovnalova H, Kubikova R, Prasek J. Striatal dopamine transporter imaging correlates with depressive symptoms and Tower of London task performance in Parkinson's disease. Mov Disord 2008; 23: 1580-1587.
27. 123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 2014; 85: 159-164.
28. Weintraub D, Newberg A, Cary M, et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med 2005; 46: 227-232.
29. Wu H, Lou C, Huang Z, Shi G. SPECT imaging of dopamine transporters with (99m)Tc-TRODAT-1 in major depression and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2011; 23: 63-67.
30. Qamhawi Z, Towey D, Shah B, et al. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease. Brain 2015; 138: 2964-2973.
31. Feldmann A, Illes Z, Kosztolanyi P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov Disord 2008; 23: 42-46.
32. Kostić V, Agosta F, Petrović I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010; 75: 857-863.
33. van Mierlo T, Chung C, Foncke E, Berendse H, van den Heuvel O. Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume. Mov Disord 2015; 30: 245-252.
34. Huang P, Xu X, Gu Q, et al. Disrupted white matter integrity in depressed versus non-depressed Parkinson's disease patients: a tract-based spatial statistics study. J Neurol Sci 2014; 346: 145-148.
35. Li W, Liu J, Skidmore F, Liu Y, Tian J, Li K. White matter microstructure changes in the thalamus in Parkinson disease with depression: a diffusion tensor MR imaging study. AJNR Am J Neuroradiol 2010; 31: 1861-1866.
36. Matsui H, Nishinaka K, Oda M, et al. Depression in Parkinson's disease diffusion tensor imaging study. J Neurol 2007; 254: 1170-1173.
37. Hu X, Song X, Yuan Y, et al. Abnormal functional connectivity of the amygdala is associated with depression in Parkinson's disease. Mov Disord 2015; 30: 238-244.
38. Lou Y, Huang P, Li D, et al. Altered brain network centrality in depressed Parkinson's disease patients. Mov Disord 2015; 30: 1777-1784.
39. Sheng K, Fang W, Su M, et al. Altered spontaneous brain activity in patients with Parkinson's disease accompanied by depressive symptoms, as revealed by regional homogeneity and functional connectivity in the prefrontal-limbic system. PLoS One 2014; 9: e84705.
40. Skidmore F, Yang M, Baxter L, et al. Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease. NeuroImage 2013; 81: 484-495.
41. Wen X, Wu X, Liu J, Li K, Yao L. Abnormal baseline brain activity in non-depressed Parkinson's disease and depressed Parkinson's disease: a resting-state functional magnetic resonance imaging study. PLoS One 2013; 8: e63691.
42. Luo C, Chen Q, Song W, et al. Resting-state fMRI study on drug-naive patients with Parkinson's disease and with depression. J Neurol Neurosurg Psychiatry 2014; 85: 675-683.
43. Becker T, Becker G, Seufert J, et al. Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 1997; 63: 590-596.
44. Walter U, Hoeppner J, Prudente-Morrissey L, et al. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 2007; 130: 1799-1807.
45. Surdhar I, Gee M, Bouchard T, Coupland N, Malykhin N, Camicioli R. Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson's disease with mild depressive symptoms. Parkinsonism Relat Disord 2012; 18: 809-813.
46. Cardoso E, Maia F, Fregni F, et al. Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus. NeuroImage 2009; 47: 467-472.
47. Huang P, Xuan M, Gu Q, et al. Abnormal amygdala function in Parkinson's disease patients and its relationship to depression. J Affect Disord 2015; 183: 263-268.
48. Berg D, Supprian T, Hofmann E, et al. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 1999; 246: 1186-1193.
49. Barone P. Neurotransmission in Parkinson's disease: beyond dopamine. Eur J Neurol 2010; 17: 364-376.
50. Aarsland D, Påhlhagen S, Ballard C, Ehrt U, Svenningsson P. Depression in Parkinson disease - epidemiology, mechanisms and management. Nat Rev Neurol 2012; 8: 35-47.
51. Erro R, Pappatà S, Amboni M, et al. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. Parkinsonism Relat Disord 2012; 18: 1034-1038.
52. Moriyama T, Felicio A, Chagas M, et al. Increased dopamine transporter density in Parkinson's disease patients with social anxiety disorder. J Neurol Sci 2011; 310: 53-57.
53. Tinaz S, Courtney M, Stern C. Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 2011; 26: 436-441.
54. Vriend C, Boedhoe P, Rutten S, Berendse H, van der Werf Y, van den Heuvel O. A smaller amygdala is associated with anxiety in Parkinson's disease: a combined FreeSurfer-VBM study. J Neurol Neurosurg Psychiatry 2015; pii: jnnp-2015-jnnp310383.
55. Lawrence A, Goerendt I, Brooks D. Apathy blunts neural response to money in Parkinson's disease. Soc Neurosci 2011; 6: 653-662.
56. Le Jeune F, Drapier D, Bourguignon A, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 2009; 73: 1746-1751.
57. Robert G, Le Jeune F, Lozachmeur C, et al. Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology 2012; 79: 1155-1160.
58. Robert G, Le Jeune F, Dondaine T, et al. Apathy and impaired emotional facial recognition networks overlap in Parkinson's disease: a PET study with conjunction analyses. J Neurol Neurosurg Psychiatry 2014; 85: 1153-1158.
59. Robert GH, Le Jeune F, Lozachmeur C, et al. Preoperative factors of apathy in subthalamic stimulated Parkinson disease: a PET study. Neurology 2014; 83: 1620-1626.
60. Thobois S, Ardouin C, Lhommee E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010; 133: 1111-1127.
61. Santangelo G, Vitale C, Picillo M, et al. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients. Parkinsonism Relat Disord 2015; 21: 489-493.
62. Isella V, Melzi P, Grimaldi M, et al. Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov Disord 2002; 17: 366-371.
63. Reijnders J, Scholtissen B, Weber W, Aalten P, Verhey F, Leentjens A. Neuroanatomical correlates of apathy in Parkinson's disease: a magnetic resonance imaging study using voxel-based morphometry. Mov Disord 2010; 25: 2318-2325.
64. Baggio H, Segura B, Garrido-Millan J, et al. Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy. Mov Disord 2015; 30: 671-679.
65. Carriere N, Besson P, Dujardin K, et al. Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis. Mov Disord 2014; 29: 897-903.
66. Aarsland D, Brønnick K, Alves G, et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 928-930.
67. Mayberg H. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003; 65: 193-207.
68. Rutten S, Ghielen I, Vriend C, et al. Anxiety in Parkinson's disease: symptom dimensions and overlap with depression and autonomic failure. Parkinsonism Relat Disord 2015; 21: 189-1993.
69. Pagonabarraga J, Kulisevsky J, Strafella A, Krack P. Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol 2015; 14: 518-531.
70. Wen M-C, Steffens D, Chen M, Zainal N. Diffusion tensor imaging studies in late-life depression: systematic review and meta-analysis. Int J Geriatr Psychiatry 2014; 29: 1173-1184.
71. de Visser L, Baars A, Lavrijsen M, van der Weerd C, van den Bos R. Decision-making performance is related to levels of anxiety and differential recruitment of frontostriatal areas in male rats. Neuroscience 2011; 184: 97-106.
72. Lavretsky H, Ballmaier M, Pham D, Toga A, Kumar A. Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study. Am J Geriatr Psychiatry 2007; 15: 386-394.